参考文献

参考文献

[1]Comas I, Chakravartti J, Small P M, et al. Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved [J]. Nature genetics, 2010, 42(6): 498-503.

[2]Cambau E, Drancourt M. Steps towards the discovery of Mycobacterium tuberculosis by Robert Koch, 1882[J]. Clinical Microbiology and Infection,2014, 20(3): 196-201.

[3]Sinha P, Gupta A, Prakash P, et al. Differentiation of Mycobacterium tuberculosis complex from non-tubercular mycobacteria by nested multiplex PCR targeting IS6110, MTP40 and 32kD alpha antigen encoding gene fragments[J]. BMC infectious diseases, 2016, 16(1): 123.

[4]Bekale R B, Du Plessis S M, Hsu N J, et al. Mycobacterium tuberculosis and interactions with the host immune system: Opportunities for nanoparticle based immunotherapeutics and vaccines[J].Pharmaceutical research,2019,36(1):8.

[5]Mishra A, Surolia A. Mycobacterium tuberculosis: surviving and indulging in an unwelcoming host[J]. IUBMB life, 2018, 70(9): 917-925.

[6]Mihaylova M M, Shaw R J. The AMPK signalling pathway coordinates cell growth, autophagy and metabolism [J]. Nature cell biology, 2011, 13(9):1016-1023.

[7]Pai M, Behr M A, Dowdy D, et al. Tuberculosis[J]. Nature reviews. Disease primers, 2016, 2: 16076.

[8]Annabel B, Anna D, Hannah M. Global tuberculosis report 2019[J]. Geneva:World Health Organization, 2019.

[9]Gideon H P, Phuah J Y, Myers A J, et al. Variability in tuberculosis granuloma T cell responses exists, but a balance of pro -and anti -inflammatory cytokines is associated with sterilization[J]. PLoS Pathog, 2015,11(1): e1004603.

[10]Barry 3rd C E, Boshoff H, Dartois V, et al. The spectrum of latent tuberculosis:rethinking the goals of prophylaxis[J]. Nature reviews. Microbiology, 2009, 7(12): 845.

[11]李佳, 刘冰靥, 王德成. 结核肉芽肿的研究新进展[J]. 海南医学, 2016, 27:3893-3896.

[12]Paige C, Bishai W R. Penitentiary or penthouse condo: the tuberculous granuloma from the microbe's point of view[J]. Cellular microbiology, 2010,12(3): 301-309.

[13]Saunders B M, Britton W J. Life and death in the granuloma: immunopathology of tuberculosis[J]. Immunology and cell biology, 2007, 85(2): 103-111.

[14]Dubovsky H. A historical basis for modern concepts of the pathogenesis of tuberculosis[J]. South African medical journal= Suid-Afrikaanse tydskrif vir geneeskunde, 1975, 49(27): 1105-1110.

[15]Liu C H,Liu H,Ge B.Innate immunity in tuberculosis:host defense vs pathogen evasion[J]. Cellular & molecular immunology, 2017, 14(12): 963-975.

[16]Erokhin V V, Lesnaia A A. Connective tissue function and fibril formation processes in fibrous-cavernous pulmonary tuberculosis[J]. Arkhiv patologii,1985, 47(4): 36.

[17]Zuo T, Fu J, Ni Z, et al. Pulmonary inflammatory Myofibroblastic tumor indistinguishable from tuberculosis: a case report in a five-year-old child with hemoptysis[J]. Journal of Cardiothoracic Surgery, 2017, 12(1): 112.

[18]BoseDasgupta S, Pieters J. Macrophage-microbe interaction: lessons learned from the pathogen Mycobacterium tuberculosis [C]//Seminars in immunopathology. Springer Berlin Heidelberg, 2018, 40(6): 577-591.

[19]Eum S Y, Kong J H, Hong M S, et al. Neutrophils are the predominant infected phagocytic cells in the airways of patients with active pulmonary TB[J]. Chest, 2010, 137(1): 122-128.

[20]Bussi C, Gutierrez M G. Mycobacterium tuberculosis infection of host cells in space and time[J]. FEMS microbiology reviews, 2019, 43(4): 341-361.

[21]Liao D, Fan Q, Bao L. The role of superoxide dismutase in the survival of Mycobacterium tuberculosis in macrophages[J]. Japanese journal of infectious diseases, 2013, 66(6): 480-488.

[22]Behr M A, Sherman D R. Mycobacterial virulence and specialized secretion:same story, different ending[J]. Nature medicine, 2007, 13(3): 286-287.

[23]Garces A, Atmakuri K, Chase M R, et al. EspA acts as a critical mediator of ESX1 -dependent virulence in Mycobacterium tuberculosis by affecting bacterial cell wall integrity[J]. PLoS Pathog, 2010, 6(6): e1000957.

[24]Tang X L, Zhou Y X, Wu S M, et al. CFP10 and ESAT6 aptamers as effective Mycobacterial antigen diagnostic reagents[J]. Journal of Infection, 2014, 69(6): 569-580.

[25]Pang X, Samten B, Cao G, et al. MprAB regulates the espA operon in Mycobacterium tuberculosis and modulates ESX-1 function and host cytokine response[J]. Journal of bacteriology, 2013, 195(1): 66-75.

[26]Chatterjee S, Dwivedi V P, Singh Y, et al. Early secreted antigen ESAT-6 of Mycobacterium tuberculosis promotes protective T helper 17 cell responses in a toll-like receptor-2-dependent manner[J]. PLoS Pathog, 2011, 7(11):e1002378.

[27]Wang X, Barnes P F, Dobos-Elder K M, et al. ESAT-6 inhibits production of IFN-γ by Mycobacterium tuberculosis-responsive human T cells [J]. The Journal of Immunology, 2009, 182(6): 3668-3677.

[28]Derrick S C, Morris S L. The ESAT6 protein of Mycobacterium tuberculosis induces apoptosis of macrophages by activating caspase expression[J].Cellular microbiology, 2007, 9(6): 1547-1555.

[29]Peng X, Luo T, Zhai X, et al. Ppe11 of mycobacterium tuberculosis can alter host inflammatory response and trigger cell death[J]. Microbial pathogenesis,2019, 126: 45-55.

[30]Tang X L, Wu S M, Xie Y, et al. Generation and application of ssDNA aptamers against glycolipid antigen ManLAM of Mycobacterium tuberculosis for TB diagnosis[J]. Journal of Infection, 2016, 72(5): 573-586.

[31]Turner J, Torrelles J B. Mannose-capped lipoarabinomannan in Mycobacterium tuberculosis pathogenesis[J]. Pathogens and Disease, 2018, 76(4): fty026.

[32]Shabaana A K, Kulangara K, Semac I, et al. Mycobacterial lipoarabinomannans modulate cytokine production in human T helper cells by interfering with raft/microdomain signalling[J]. Cellular and Molecular Life Sciences CMLS, 2005,62(2): 179-187.

[33]Koh V H Q, Ng S L, Ang M L T, et al. Role and contribution of pulmonary CD103+ dendritic cells in the adaptive immune response to Mycobacterium tuberculosis[J]. Tuberculosis, 2017, 102: 34-46.

[34]Maione V, Ruggiero A, Russo L, et al. NMR structure and dynamics of the resuscitation promoting factor RpfC catalytic domain[J]. PloS one, 2015, 10(11): e0142807.

[35]Olsen A, Chen Y, Ji Q, et al. Targeting Mycobacterium tuberculosis tumor necrosis factor alpha -downregulating genes for the development of antituberculous vaccines[J]. MBio, 2016, 7(3).

[36]Tiwari S, Van Tonder A J, Vilchèze C, et al. Arginine-deprivation–induced oxidative damage sterilizes Mycobacterium tuberculosis[J]. Proceedings of the National Academy of Sciences, 2018, 115(39): 9779-9784.

[37]Kurthkoti K, Varshney U. Distinct mechanisms of DNA repair in mycobacteria and their implications in attenuation of the pathogen growth[J]. Mechanisms of ageing and development, 2012, 133(4): 138-146.

[38]Mahesh P P, Retnakumar R J, Mundayoor S. Downregulation of vimentin in macrophages infected with live Mycobacterium tuberculosis is mediated by Reactive Oxygen Species[J]. Scientific reports, 2016, 6: 21526.

[39]Schön T, Elmberger G, Negesse Y, et al. Local production of nitric oxide in patients with tuberculosis[J]. The International Journal of Tuberculosis and Lung Disease, 2004, 8(9): 1134-1137.

[40]Braverman J, Stanley S A. Nitric oxide modulates macrophage responses to Mycobacterium tuberculosis infection through activation of HIF -1α and repression of NF-κB[J].The Journal of Immunology,2017,199(5):1805-1816.[41]Lovewell R R, Sassetti C M, VanderVen B C. Chewing the fat: lipid metabolism and homeostasis during M. tuberculosis infection [J]. Current opinion in microbiology, 2016, 29: 30-36.

[42]Rao M, Cadieux N, Fitzpatrick M, et al. Mycobacterium tuberculosis proteins involved in cell wall lipid biosynthesis improve BCG vaccine efficacy in a murine TB model[J].International Journal of Infectious Diseases,2017,56:274-282.

[43]Nazarova E V, Montague C R, La T, et al. Rv3723/LucA coordinates fatty acid and cholesterol uptake in Mycobacterium tuberculosis [J]. Elife, 2017, 6:e26969.

[44]Kiessling P, Lledo-Garcia R, Watanabe S, et al. The FcRn inhibito r rozanolixizumab reduces human serum IgG concentration: A randomized phase 1 study[J]. Science translational medicine, 2017, 9(414):eaan1208.

[45]Anderson C L, Grey H M. Receptors for aggregated IgG on mouse lymphocytes: their presence on thymocytes, thymus -derived, and bone marrow-derived lymphocytes[J]. The Journal of experimental medicine, 1974,139(5): 1175-1188.

[46]de Taeye S W, Rispens T, Vidarsson G. The ligands for human IgG and their effector functions[J]. Antibodies, 2019, 8(2): 30.

[47]Bournazos S, Wang T T, Ravetch J V. The role and function of Fcγ receptors on myeloid cells[J]. Myeloid Cells in Health and Disease: A Synthesis, 2017:405-427.

[48]Ward E S, Ober R J. Targeting FcRn to generate antibody-based therapeutics[J]. Trends in pharmacological sciences, 2018, 39(10): 892-904.

[49]Rath T, Kuo T T, Baker K, et al. The immunologic functions of the neonatal Fc receptor for IgG[J]. Journal of clinical immunology, 2013, 33(1): 9-17.

[50]Maeda A, Iwayanagi Y, Haraya K, et al. Identification of human IgG1 variant with enhanced FcRn binding and without increased binding to rheumatoid factor autoantibody[C]//MAbs. Taylor & Francis, 2017, 9(5): 844-853.

[51]Roopenian D C, Akilesh S. FcRn: the neonatal Fc receptor comes of age[J].Nature reviews immunology, 2007, 7(9): 715-725.

[52]Bondt A, Selman M H J, Deelder A M, et al. Association between galactosylation of immunoglobulin G and improvement of rheumatoid arthritis during pregnancy is independent of sialylation [J]. Journal of proteome research, 2013, 12(10): 4522-4531.

[53]Ardeniz Ö, Unger S, Onay H, et al. β2-Microglobulin deficiency causes a complex immunodeficiency of the innate and adaptive immune system[J].Journal of Allergy and Clinical Immunology, 2015, 136(2): 392-401.

[54]Hashem L, Swedrowska M, Vllasaliu D. Intestinal uptake and transport of albumin nanoparticles: Potential for oral delivery[J]. Nanomedicine, 2018, 13(11): 1255-1265.

[55]Mohanty S, Kim J, Ganesan L P, et al. Abundant intracellular IgG in enterocytes and endoderm lacking FcRn[J]. PloS one, 2013, 8(7): e70863.

[56]Viuff D, Antunes F, Evans L, et al. Generation of a double transgenic humanized neonatal Fc receptor (FcRn)/albumin mouse to study the pharmacokinetics of albumin-linked drugs[J]. Journal of Controlled Release,2016, 223: 22-30.

[57]Montoyo H P, Vaccaro C, Hafner M, et al. Conditional deletion of the MHC class I-related receptor FcRn reveals the sites of IgG homeostasis in mice[J].Proceedings of the National Academy of Sciences, 2009, 106(8): 2788-2793.